- Home
- MREO vs PVL Comparison
MREO vs PVL Comparison
Compare MREO & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | PVL |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 60.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | PVL |
|---|---|---|
| Price | $0.34 | $1.78 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $1.96 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 46.2K |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | ★ 11.59% |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $1.58 |
| 52 Week High | $2.37 | $2.01 |
Technical Indicators
Market Signals| Indicator | MREO | PVL |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 41.23 |
| Support Level | $0.35 | $1.73 |
| Resistance Level | $0.35 | $1.84 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 47.31 | 22.22 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.